The global Point of Care Lipid Test Market, which was estimated at USD 38.7 billion in 2022, is forecasted to witness significant expansion, reaching USD 65.5 billion by 2030. This growth trajectory reflects a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period spanning from 2023 to 2030.

Get sample PDF @ https://www.snsinsider.com/sample-request/4003 

Key Players

The major key players are Vital Biosciences, Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche, ACON Laboratories, Inc, BioMerieux SA, Bio-Rad Laboratories. Inc, HemoCue AB (Danaher Corporation), Dexcom, Inc, Medtronic Plc, Meridian Bioscience, Nova Biomedical, OraSure Technologies, Siemens Healthineers AG, and BioLytical Laboratories Inc., and Others.

Point of Care Lipid Tests play a crucial role in the timely diagnosis and management of various cardiovascular conditions by providing rapid and accurate results outside of traditional laboratory settings. These tests measure lipid levels in blood, including cholesterol and triglycerides, helping healthcare professionals assess a patient's risk of heart disease and formulate appropriate treatment plans. The convenience, accessibility, and efficiency of Point of Care Lipid Tests make them indispensable tools in preventive healthcare and chronic disease management.

The steady growth of the Point of Care Lipid Test market can be attributed to several factors, including the increasing prevalence of cardiovascular diseases globally, rising awareness about the importance of early detection and management of lipid disorders, and technological advancements in point-of-care testing devices. Moreover, the COVID-19 pandemic has further emphasized the need for decentralized diagnostic solutions that enable rapid and efficient testing, driving the adoption of Point of Care Lipid Tests across healthcare settings.

KEY SEGMENTS

By Product

  • Glucose monitoring
  •  
  • Strips
  •  
  • Meters
  •  
  • Lancets
  •  
  • Cardiometabolic testing products
  •  
  • Cardiac marker testing products
  •  
  • hsTnl
  •  
  • BNP
  •  
  • D-dimer
  •  
  • CK-MB
  •  
  • Myoglobin
  •  
  • Others
  •  
  • Blood gas/electrolytes testing products
  •  
  •  HBAIC testing products
  •  
  • Infectious disease testing products
  •  
  • Influenza testing products
  •  
  • HIV testing products
  •  
  • Hepatitis C testing products
  •  
  • Sexually transmitted disease (STD) testing products
  •  
  • Healthcare-associated infection (HAl) testing products
  •  
  • Respiratory infection testing products
  •  
  • Tropical disease testing products
  •  
  • Others
  •  
  • Coagulation testing products
  •  
  • PT/INR testing products
  •  
  • Activated clotting time (ACT/APTT) testing products
  •  
  • Pregnancy and fertility testing products
  •  
  • Pregnancy testing products
  •  
  • Fertility testing products
  •  
  • Tumor/cancer marker testing products
  •  
  • Cholesterol testing products
  •  
  • Hematology testing products
  •  
  • Drug-of-abuse (DoA) testing products
  •  
  • Fecal occult testing products
  •  
  • Urinalysis testing products
  •  
  • Others

By Technology

 

  • Lateral flow assays
  •  
  • Dipsticks
  •  
  • Microfluidics
  •  
  • Molecular diagnostics
  •  
  • Immunoassays
  •  
  • Agglutination assays
  •  
  • Flow-through
  •  
  • Solid phase
  •  
  • Biosensors

By Prescription

 

  • OTC testing
  •  
  • Prescription-based testing

By Application

 

  • Cardio metabolic testing
  •  
  • Infectious disease testing
  •  
  • Nephrology testing
  •  
  • Drug-of-abuse testing
  •  
  • Blood glucose testing
  •  
  • Pregnancy testing
  •  
  • Cancer biomarker testing
  •  
  • Others

By End-use

 

  • Hospitals
  •  
  • Diagnostic centers
  •  
  • Research laboratories
  •  
  • Home-care settings
  •  
  •  Others

Geographically, North America currently dominates the Point of Care Lipid Test market, owing to factors such as the high burden of cardiovascular diseases, well-established healthcare infrastructure, and favorable reimbursement policies. However, Asia-Pacific is anticipated to exhibit the highest growth rate during the forecast period, fueled by factors such as the growing aging population, increasing healthcare expenditure, and rising awareness about preventive healthcare measures in emerging economies.

Key players operating in the Point of Care Lipid Test market include Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Alere Inc. (now part of Abbott), and Quidel Corporation, among others. These companies are focusing on product innovations, strategic collaborations, and geographical expansion to strengthen their market position and meet the evolving needs of healthcare providers and patients worldwide.

As the global burden of cardiovascular diseases continues to rise, the demand for Point of Care Lipid Tests is expected to grow, driven by the need for timely and accurate diagnostic solutions. With ongoing advancements in technology and increasing investments in preventive healthcare, the Point of Care Lipid Test market is poised for significant expansion in the coming years, contributing to improved patient outcomes and reduced healthcare costs.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com